INTRODUCTION
Natural regulatory T (Treg) cells play an important role in the preservation of self-tolerance (Fontenot and Rudensky, 2005; Izcue et al., 2006; Sakaguchi, 2004) . Although there are both CD8 + and CD4 + Foxp3 + cells, here, we use ''Treg cell'' in the traditionally defined manner to indicate CD4 + Foxp3 + , and mostly CD25 + , cells. Genetic ablation of Treg cell development resulting from Foxp3 deficiency leads to overwhelming autoimmunity and early death in both humans (Bennett et al., 2001 ) and mice (Fontenot et al., 2003) . Moreover, acute depletion of Foxp3-expressing cells turns a normal resting immune system into one that is hyperactive and uncontrolled, resulting in the death of an adult animal within a mere 10 days (Kim et al., 2007; Lahl et al., 2007) . Thus, Treg cells are required throughout life to preserve immune homeostasis.
A characteristic feature of Treg cells is their ability to recognize self-antigens (Apostolou et al., 2002; Jordan et al., 2001; Seddon and Mason, 1999; Taguchi et al., 1994) . This is consistent with the finding that the TCR repertoires of Treg and non-Treg cells are different with a small degree of overlap (Hsieh et al., 2004 (Hsieh et al., , 2006 Pacholczyk et al., 2006; Wong et al., 2007) . Importantly, self-reactivity appears to be required for Treg cells to maintain self-tolerance and prevent autoimmunity in TCR transgenic and nontransgenic models (Samy et al., 2006; Seddon and Mason, 1999; Taguchi et al., 1994; Tang et al., 2004) .
Although it is commonly accepted that Treg cell development predominantly occurs in the thymus (Hsieh et al., 2006; Itoh et al., 1999; Pacholczyk et al., 2006; Wong et al., 2007) , the mechanisms by which this occurs remain controversial. Monoclonal TCR transgenic studies suggested that thymic encounter with ''self-antigen'' expressed as a second transgene facilitates Treg cell development (Apostolou et al., 2002; Jordan et al., 2001) . A report with a different ab-TCR, however, argued that the relative increase in the Treg cell subset was due to preferential deletion of non-Treg cells bearing self-reactive TCRs, favoring a stochastic-selective, rather than instructive, model (Van Santen et al., 2004) .
Cytokines, primarily IL-2, have also been suggested to play a role in thymic Treg cell development. IL-2Rb (CD122)-deficient mice exhibit a decreased number of thymic Treg cells (Bayer et al., 2007; Burchill et al., 2007; Malek et al., 2002) . However, other studies have argued that IL-2 is not critical for thymic Treg cell development, because IL-2-deficient mice have only a 50% decrease in thymic Treg cell numbers (D'Cruz and Klein, 2005; Fontenot et al., 2005b) .
Finally, a recent report has suggested that unknown trans-acting factors that act on ''double-negative'' CD4 -
CD8
-cells, which
have not yet expressed TCR, play an important role in the process of thymic Treg cell development (Pennington et al., 2006) . How these factors might skew certain TCRs into the Treg subset is unclear. This model has recently attracted proponents based on the report that non-self-, rather than self-, antigens represent the cognate antigens of Treg cells (Pacholczyk et al., 2007) . Thus, the developmental steps that divert thymocytes into the Treg cell subset, and the relationship of those steps to TCR specificity and cytokines, remain ill defined and controversial. We reasoned that the study of thymic Treg cell differentiation, like any other developmental system, would be greatly simplified by the in vivo identification of an intermediate in this process, i.e., a Treg cell precursor. Although many cells may be considered precursors, including the aforementioned double-negative cells (Pennington et al., 2006) , we were interested in cells that are closer in the developmental program to expressing Foxp3, the best available marker for Treg cells (Fontenot et al., 2005c) . Other studies have examined cells that were induced to express Foxp3 but were unable to make functional protein (Gavin et al., 2007; Lin et al., 2007) . Although these studies are important in addressing the contribution of Foxp3 to the Treg cell phenotype, they shed little light regarding the mechanisms that actually induce Foxp3. Finally, it has been reported that CD25 hi   Foxp3   -CD4   +   CD8 -(CD4SP) thymocytes are observed prior to the appearance of Foxp3 + cells in the neonatal period (Fontenot et al., 2005a) . Although it was suggested that these cells may be Treg cell precursors, this was not experimentally demonstrated. Thus, the developmental destination of the CD25 hi cells is unknown, because these cells could alternatively become negatively selected (Kishimoto et al., 1995) or exported into the periphery. Based on this study (Fontenot et al., 2005a) and our own observations, we formally tested whether the CD25 hi Foxp3 -CD4SP subset contained Treg cell precursors. We found that this subset was highly enriched in cells that express Foxp3 after intrathymic transfer. Surprisingly, these Treg cell precursors appeared to be at a penultimate step in Treg cell differentiation, requiring only non-TCR-derived signals to express Foxp3 in vivo and a minimal quantity of IL-2 in vitro. Because the ability of IL-2 to induce Foxp3 correlated with the ability to detect proximal IL-2 signaling, we propose that Treg cell development occurs via an instructive, rather than stochastic-selective, model whereby self-reactive thymocytes upregulate components of the proximal IL-2 signaling pathway to compete for cytokinemediated induction of Foxp3. (Fontenot et al., 2005c) . By using a variety of phenotypic markers, we were struck by the overlap in GITR and CD25 expression between the Treg cells and a subset of Foxp3 -CD4SP thymocytes ( Figure 1A ). Of note, both GITR and CD25, the IL-2 receptor a chain, have been used as markers for Treg cells. This CD25 hi population also arises in the neonatal period immediately prior to the development of Foxp3 + thymocytes (Fontenot et al., 2005a) and is greatly diminished in TCR transgenic 3 Rag2-deficient mice that harbor few, if any, Treg cells (Apostolou et al., 2002) . The CD25 hi GITR hi subset represents approximately 3% of CD4SP and 0.2% of all thymocytes. The low frequency of these cells required magnetic bead depletion of CD8 + cells followed by flow cytometric sorting of an approximately 1% target population. To test whether thymic subsets were enriched for precursors to Treg cells, we performed intrathymic transfer to assess the frequency of cells that upregulated the expression of Foxp3. For these in vivo experiments, we avoided the use of anti-GITR DTA-1 monoclonal antibody because of its potentially activating properties in vivo (Shimizu et al., 2002) . Three days after intrathymic transfer, we found that on average, 13.8% of purified CD25 Figure 1D ; see Figure S1 available online The notion that TCR stimulation may be responsible for the generation of CD25 hi cells is consistent with several studies with polyclonal TCR models that have uniformly shown that the Treg TCR repertoire is different from, but overlapping with, the non-Treg TCR repertoire in the thymus (Hsieh et al., 2006; Pacholczyk et al., 2006; Wong et al., 2007) . However, it is unclear whether TCR-derived signals played a direct role in the developmental process resulting in the induction of Foxp3, or whether it acted in a circumstantial fashion by favoring the negative selection of self-reactive Foxp3 -versus Foxp3 + cells (Van Santen et al., 2004) . In fact, it has been argued that TCR specificity to self-antigen plays little to no role in thymic Treg cell development (Pacholczyk et al., 2007) , implying that the cell-surface phenotype consistent with TCR activation may be a stochastic and antigen-nonspecific occurrence. We therefore asked whether the population of Treg cell precursors within the CD25 hi CD4SP subset arose because of TCR specificity characteristic of Treg, and not non-Treg, cells. To test this, we utilized a fixed TCR-b model for tracking the developmental fate assigned to individual TCRs (Hsieh et al., 2004 (Hsieh et al., , 2006 . We purified T cells from the Foxp3 + Treg, and CD25 hi GITR hi and CD25 lo GITR int Foxp3 -CD4SP subsets, and we sequenced TRAV14 (V a 2) chains as previously described (Hsieh et al., 2006) . GITR lo CD4SP cells were excluded because they appear to be immature thymocytes that are transiting to either CD4SP or CD8SP cells (data not shown). We found that the thymic Treg TCR repertoire was more similar to the CD25 hi GITR hi subset than the CD25 lo GITR int subset (Figure 2A ; Figure S2 ), consistent with the notion that the Treg cell precursors in the CD25 Figure 1B ). Similar to our previous results (Hsieh et al., 2006) 
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-subset. Importantly, once that developmental stage is achieved, further development is independent of TCR-derived signals.
IL-2 Is Sufficient for Foxp3 Induction In Vitro
The observation that deletion of the common g-chain of the IL-2 receptor completely inhibited the development of thymic Treg cells (Fontenot et al., 2005b) suggested that cytokines may be Figure 4C ; Figure S3 ). CD25 hi cells that upregulated Foxp3 were suppressive in vitro, suggesting that they have acquired functional characteristics of Treg cells ( Figure 4D) . Thus, the administration of a single cytokine to precursors within the CD25 hi subset is sufficient for inducing Foxp3, the final step in Treg cell development (Gavin et al., 2007) .
The enrichment of Treg cell precursors within the CD25 hi CD4SP thymocytes subset suggested that the presence of CD25 may facilitate the induction of Foxp3. We sorted four Foxp3 -thymocyte subsets with varying expression of CD25 and GITR, three of which (denoted a, b, and c in Figure 4E ) were in areas of overlap between the Foxp3 + and Foxp3 -subsets. Consistent with the hypothesis that IL-2 signaling plays a role in Foxp3 acquisition, we found that the amount of CD25 correlated with the frequency of cells that upregulate Foxp3 in response to IL-2.
IL-2 and IL-15 Are the Common g-Chain Cytokines that Induce Foxp3
An alternative explanation for the above results is that IL-2, instead of directly inducing Foxp3 expression, may simply permit the expansion or survival of thymocytes precommitted to becoming Treg cells. We first assessed whether IL-2 induced the proliferation of CD25 hi cells that become Foxp3 + . Because CFSE interfered with the use of Foxp3 gfp as a Treg cell marker, we used the fluorescent dye DDAO-SE to track cell proliferation via its dilution. We observed essentially no decrease in DDAO-SE staining during our 24 hr short-term IL-2 culture, though the induction of Foxp3 was easily visualized ( Figure 5A ). Next, we performed real-time quantitative RT-PCR for Foxp3 to evaluate time points that could not be easily visualized by flow cytometry because of the time required for protein folding of GFP for fluorescence ( Figure 4B ). We observed that IL-2 rapidly induced Foxp3 mRNA by 3 hr ( Figure 5B ). Importantly, delay of IL-2 administration by 3 hr did not negatively affect the induction of Foxp3 mRNA, arguing that IL-2 is not simply a survival or growth factor allowing the expression of Foxp3 via a preprogrammed path, but that IL-2 directly induces the expression of Foxp3 in Treg cell precursors. Because a deficiency in the common g-chain, and not IL-2, results in a virtual absence of thymic Treg cells (Fontenot et al., 2005b) , we also tested the ability of other common g-chain cytokines to induce Foxp3 in CD25 hi CD4SP thymocytes ( Figure 5C ).
Of the cytokines tested, only IL-2 and IL-15 were effective in inducing Foxp3 expression in a high proportion of CD25 hi cells.
However, the in vitro potency of these two cytokines for inducing gfp 3 Tcra +/-mice and TRAV14 (V a 2) TCRa sequences obtained as previously described (Hsieh et al., 2004) . Data shown are pooled from two independent experiments ( Figure S2 ). Each pie graph represents the TCR-a sequences in the data set that were also found in at least one other thymic data set. The portion of the TCR-a sequences that overlaps another data set is indicated by a different color in the pie graph, and the data set overlapped is denoted by an arrow. The number of TCR-a chains that were not found in another subset was similar between the three subsets (73%, 65%, and 67% for CD25 lo , CD25 hi , and Foxp3 + subsets, respectively).
(B) Comparison of TCR-a sequences from thymic and peripheral subsets. Unique TCR-a sequences from the indicated thymic CD4SP subsets that were also found in the peripheral TCR data sets are plotted on the x axis. Each vertical bar represents the likelihood that an individual thymic TCR would be found within the peripheral Foxp3 expression differed by at least 50-fold ( Figure 5D ), although in trans presentation may enhance the potency of IL-15 in vivo (Burkett et al., 2004) . It should be noted that these data may underestimate the true sensitivity of the Treg cell precursors to IL-2 induction because of our inability to purify the CD25 hi subset without the use of monoclonal antibodies to CD25, which inhibit IL-2 signaling. Nevertheless, the dose of IL-2 required to achieve 15% induction of Foxp3 expression, the amount observed after intrathymic transfer, was only 75 pg/ml. This represents a molar concentration of 4.4 pM, which is in the 10 pM Kd range of the high-affinity IL-2Rabg receptor (Sharon et al., 1986) . In vitro blockade of IL-2 did not reveal a role for endogenous production of IL-2 ( Figure S4 ). Although TGF-b has been suggested to be important for the development of Foxp3 + cells from peripheral T cells in vitro (Chen et al., 2003) , we did not observe a role for TGF-b in our in vitro thymocyte assay ( Figure S5 ), consistent with in vivo observations from conditional T cell knockouts of TGF-bRII (Li et al., 2006; Marie et al., 2006) . From these data, we conclude that IL-2 and IL-15 are the predominant common g-chain cytokines responsible for induction of Foxp3 in CD25 hi Treg cell precursors.
Regulation of Proximal IL-2 Signaling during the Process of Treg Cell Development
The ability of cytokines to induce Foxp3 in CD25
hi Treg cell precursors but not CD25 lo cells could be due to a differential ability of those cells to respond at the level of proximal signaling. Because Janus kinase-1 (Jak1)-and Jak3-STAT5 is the main signaling pathway that is activated by IL-2, we determined whether Jak kinase activity is required for the induction of Foxp3. Indeed, pharmacologic inhibition of Jak kinase activity prevented the expression of Foxp3 ( Figure 6A ). Thus, Jak kinase activation, presumably via STAT5, is required for the induction of Foxp3 in Treg cell precursors.
It has previously been reported that STAT5 is required for the development of Treg cells, because STAT5a 3 STAT5b-doubledeficient mice are greatly diminished in Treg cell numbers (Burchill et al., 2007; Yao et al., 2007) . We therefore analyzed the activation status of STAT5 via intracellular staining of phosphorylated STAT5 ( Figure 6B) Because our analysis has thus far addressed only the expression of CD25, the a chain of the trimeric high-affinity IL-2Rabg, it was possible that other proximal IL-2 components may be missing in the CD25 hi cells unable to induce phospho-STAT5. Because the common g-chain is considered to be constitutively expressed, we assessed the expression of CD122 (IL-2Rb) on the CD25 hi
Foxp3
-subset ( Figure 7A ). Because only one-third of CD25 hi cells expressed high amounts of CD122, it was possible that CD122 expression correlated with the ability to induce phospho-STAT5 in response to IL-2. We found that almost all sorted 
CD25
hi CD122 hi cells were capable of inducing phospho-STAT5, whereas only 30% of CD25 hi CD122 lo cells did so ( Figure 7B ). The ability to induce phospho-STAT5 correlated with the ability to induce Foxp3 after 24 hr of culture ( Figure 7C ). Figure S6 ). Thus, we propose that the generation of the cytokine-responsive Treg cell precursor requires the induction of an unknown factor that permits Foxp3 expression, in concert with the upregulation of the proximal IL-2 signaling machinery.
Although not absolute, the clear shift from IL-7 to IL-2 signaling between CD25 lo and CD25 hi Foxp3 -cells suggested that CD127
(IL-7Ra) may be downregulated during the process of thymic Treg cell development. Indeed, the upregulation of CD122 in CD25 hi cells was associated with a decrease in CD127 expression ( Figure 7D ). We then sorted subsets of CD25 hi cells based on CD122 and CD127 expression and assessed the ability of IL-2 to induce Foxp3. We found that the expression of CD127 marked a subpopulation of CD25 hi cells that have a low frequency of cytokine-responsive Treg cell precursors ( Figure 7E ). Although further studies are required, these data suggest that Treg cell development within the CD25 hi subset may be phenotypically described by the downregulation of CD127 followed by the upregulation of CD122.
DISCUSSION
The observation that a subset of CD25 hi Foxp3 -CD4SP thymocytes contains precursors for natural Treg cells has enabled us to generate a framework for thymic Treg cell development. Temporally, our data suggest that this process can be divided into at least two distinct stages based on the requirement for TCRderived signals. The initial TCR-dependent generation of Treg cell precursors in the CD25 hi subset is based on the observation Immunity Two-Step Process for Thymic Treg Cell Development that this subset is enriched in TCRs normally found in the Treg cell subset. Alterations in the TCR repertoire in the CD25 hi subset could result from stochastic-selective or instructive TCR-derived signals. We favor the latter because ab-TCR transgenic mice on a Rag-deficient background, which do not develop Treg cells, are also deficient in this CD25 hi population (Apostolou et al., 2002) . Furthermore, upregulation of CD25 and CD69 has long been associated with TCR activation (Kishimoto and Sprent, 1997) , supporting the notion that generation of CD25 hi cells is a TCR-instructive event.
The direct involvement of TCR signaling in this model is in clear contrast with a recent report suggesting that Treg cells do not display increased avidity toward self-antigens (Pacholczyk et al., 2007) . Their observation that Treg TCRs do not show strong activation to self-antigens on splenic APCs is consistent with our previously published report, where we suggested that the avidity of the majority of Treg TCRs for self ligands is below the range characteristic of conventional T cell responses (Hsieh et al., 2004) . It is unclear whether hybridoma cell lines generated without prior immunization would be sufficiently sensitive to test this possibility. Their suggestion that the overlap between Treg and non-Treg TCRs is greater when assessed in the absence of frequency information does not, in our opinion, imply that TCR specificity is not important, but rather that control of Treg development by TCR specificity is not absolute, but probabilistic (Hsieh et al., 2004) . When the frequency of each TCR is taken into account, their data, like ours and others (Hsieh et al., 2004 (Hsieh et al., , 2006 Wong et al., 2007) , clearly demonstrate that the TCR repertoires of Treg and non-Treg cells differ, as shown by the fact that many TCRs are preferentially found in one or the other subset. Although we cannot formally exclude a TCR-independent event that selectively upregulates CD25 on a subset of T cells that expresses a different (but overlapping) set of TCRs, we believe that the simplest interpretation is that the CD25 hi subset is generated because of moderate avidity TCR interaction with self-antigens below or around the threshold for negative selection.
Other molecules may also play a role in the TCR-dependent phase. Mice deficient in the TCR costimulator CD28 show a diminished number of Treg cells (Salomon et al., 2000) . Further studies have found that CD28 provides a cell-intrinsic signal independent of its ability to promote cell-extrinsic signals such as IL-2 (Tai et al., 2005) , suggesting that CD28 acts, in part, during the TCR-dependent phase of Treg cell development. Cytokines may also be involved in this TCR-dependent stage, 
Foxp3
-CD4SP cells were cultured in the presence of 5 ng/ml murine IL-7 with or without 5 U/ml human IL-2 for either 3 hr, or for the last 3 hr of a 6 hr culture, and assessed for Foxp3 mRNA expression by real-time RT-PCR normalized to HPRT expression (Hori et al., 2003) . For reference, freshly isolated Foxp3 + thymocytes express 3.6 normalized amount of Foxp3 mRNA. Data shown are mean ± SD (n = 3).
(C) Analysis of common g-chain cytokines for their ability to induce Foxp3. Sorted CD25 hi Foxp3 -CD4SP cells were assayed for Foxp3 induction at 24 hr with the indicated murine cytokines (100 ng/ml) and IL-7 (5 ng/ml). Titration of cytokines down to 1 ng/ml did not enhance the percentage of Immunity Two-Step Process for Thymic Treg Cell Development because mice deficient in the common g-chain show substantial decrease in CD25 hi Foxp3 -cells (Fontenot et al., 2005b) . However, the proportion of those CD25 hi cells that are Treg cell precursors is unknown, and additional studies are required.
After a period of TCR-dependent maturation, Treg cell development enters a TCR-independent phase. Cells within this phase are characterized by their ability to rapidly express Foxp3 in vitro after exposure to IL-2 or IL-15 in the complete absence of antigen-presenting cells. The ability to upregulate Foxp3 correlates with the ability of the cell population to induce phospho-STAT5 upon IL-2 stimulation, implying that a principle component of the earlier TCR-dependent step is the upregulation of the proximal IL-2 signaling pathway. However, it is likely that TCR or other signals may generate other unknown factors that render the Foxp3 promoter permissive to transcription after IL-2-derived signals, because the ability to induce phospho-STAT5 does not strictly equate with the ability to induce Foxp3. In concert with this putative unknown factor, it seems likely that the molecular mechanism by which IL-2 and IL-15 induce Foxp3 is STAT5, which has binding sites within the Foxp3 promoter (Burchill et al., 2007; Yao et al., 2007) .
Our in vitro data suggest that IL-2 plays a more prominent role in Treg cell development than IL-15. This may be related to differences in receptor efficiencies, because CD25, but not IL-15Ra, is markedly upregulated on Treg cell precursors (data not shown). Although in trans presentation of IL-15 would enhance its signaling in vivo, the notion that IL-2 plays a greater role than IL-15 in Treg cell development is consistent with previous reports. For example, IL-2-or CD25-deficient mice show impairment in thymic Treg cell development, with approximately 50% of normal Treg cell numbers in CD4SP thymocytes (Fontenot et al., 2005b) , and develop lymphoproliferative disease, whereas IL-15-deficient mice show only a modest defect in Treg cell numbers and have no obvious autoimmunity (Burchill et al., 2007) . However, mice deficient in both IL-2 and IL-15 exhibit marked deficiency in thymic Treg cell development (Burchill et al., 2007) . The most compelling evidence for the hierarchy of IL-2 over IL-15 is demonstrated by the observation that thymocytes unable to express CD25 are 80% less competitive versus wildtype thymocytes in developing Foxp3 + Treg cells in mixed bone marrow chimeras (Fontenot et al., 2005b) . These data suggest that IL-15 or other cytokines compensate poorly for IL-2 in a more natural environment than a full knockout animal. Taken together, these data strongly suggest that IL-15 is not required for thymic Treg cell development when IL-2 is present, but that IL-15 can partially compensate when IL-2 is completely absent.
It appears that the source of IL-2 is likely to be T cells themselves, because bone marrow chimeras with IL-2-deficient donors into wild-type hosts were phenotypically similar to that of IL-2-deficient mice (Tai et al., 2005) . Furthermore, they found that IL-2 can exert its effect in a paracrine manner, as shown by the fact that IL-2-deficient and sufficient thymocytes showed equal expression of CD25 in a mixed bone marrow chimera. Although the spontaneous production of IL-2 is difficult to observe in situ, experimental induction of TCR activation in vivo suggested that thymocytes undergoing apoptosis can release IL-2 (Bassiri and Carding, 2001) .
Our data suggest that only a portion of CD25 hi cells are cytokine-responsive precursors to Treg cells. Based on our adoptive transfer studies, it appears that many of the cells in the CD25 hi subset can survive as CD25 lo non-Treg cells in the periphery.
The TCR tracking studies suggest that many TCRs thought to be ''non-Treg'' cell associated can end up in the CD25 hi subset. Potentially, this could be due to weaker TCR-derived signals that are sufficient to upregulate CD25, but not the rest of the proximal IL-2 signaling machinery or other factors required for Foxp3 expression. Additionally, other unknown factors may be necessary along with TCR signals to generate Treg cell precursors. We hi and Foxp3 + CD4SP subsets are of similar size).
Although the rates of Treg cell development and thymic export are unknown, the presence of a large precursor population hints at an in vivo bottleneck. This is supported by the finding that only half of the cells capable of expressing Foxp3 as assessed in vitro does so after in vivo transfer. Competition for limiting cytokines may cause the bottleneck, thus promoting the preferential selection of Treg cells from thymocytes that express the highest amount of CD25. If the expression of CD25 correlates with the degree of TCR activation, and thus self-reactivity, this competition for IL-2 would provide additional selection pressure for a more self-reactive Treg TCR repertoire. This is consistent with the previously discussed results from mixed bone marrow chimeras in which the CD25-deficient thymocytes were much less competitive than CD25-sufficient cells (Fontenot et al., 2005b) . Further support for this hypothesis comes from the observation that the provision of tonic IL-2 signal during thymic development via a transgenic constitutively active STAT5b skews thymic Treg cell development to include many more T cells that are normally destined to be non-Treg cells (Burchill et al., 2008) . CD25-mediated IL-2 signaling is therefore an important process for selecting the self-reactive Treg TCR repertoire, as indicated by the fact that bypassing it results in an expansion of the Treg TCR avidity window for self-antigens into the realm normally reserved for positive selection of non-Treg cells. The observation that TGF-b appears to be important for peripheral, but not thymic, Treg cell development suggests that the two processes may be distinct (Chen et al., 2003) . However, we have found in preliminary studies that an analogous population of cytokine-responsive Treg cell precursors exists in the periphery, albeit at a lower frequency. The peripheral CD25 hi
-subset may comprise both Treg cell precursors as well as recently activated non-Treg effector cells. These initial results suggest that although peripheral and thymic Treg differentiation may require different initial signals, the latter stages may utilize a common developmental pathway. In summary, our observations favor an instructive model for thymic Treg cell development that occurs in at least two sequential stages. We propose that TCR signaling results in the upregulation of CD25 and other components of the proximal IL-2 signaling pathway, and potentially a putative permissive factor for Foxp3 expression. CD25 would offer competitive fitness for the acquisition of IL-2, which would directly induce Foxp3 expression and finalize Treg cell development (Gavin et al., 2007) . The time required to complete this two-step process may explain the historic observation that CD4SP cells can spend more than a week in thymus. Thus, the relationship between TCR activation, IL-2R expression, and induction of Foxp3 by IL-2 may explain the apparent bias toward self-reactivity within the Treg cell subset, enabling thymic Treg cell emigrants to enforce dominant tolerance upon self-recognition in the periphery.
EXPERIMENTAL PROCEDURES Mice
Foxp3
gfp reporter knockin and TCli TCR-b transgenic mice were kindly provided by A. Rudensky (U. Washington, Seattle, WA). MHC class II (H-2
DAb1-Ea
), Tcrb, and Tcra knockout animals were obtained from the Jackson Laboratory, and B6.SJL (CD45.1) was obtained from the National Cancer Institute. 5-to 8-week-old Foxp3 gfp mice were used in all instances where Foxp3 protein expression is evaluated. Animals were housed in a specific pathogen-free animal facility at Washington University and were used according to protocols approved by the Institutional Animal Care and Use Committee.
Reagents
Monoclonal antibodies were purchased from eBioscience (San Diego, CA) and Becton Dickenson (San Jose, CA). IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21 were obtained from Peprotech (Rocky Hill, NJ). JAK inhibitor I was purchased from Calbiochem (San Diego, CA). CFSE and DDAO-SE were purchased from Invitrogen (Carlsbad, CA). Recombinant human TGF-b and anti-TGF-b (1D11) was obtained from R&D Systems (Minneapolis, MN).
Cell Purification CD8 + thymocytes from Foxp3 gfp mice were labeled with biotinylated CD8 antibody (eBioscience) and anti-biotin microbeads (Miltenyi Biotech, Auburn, CA), and then depleted by autoMACS magnetic bead separation (Miltenyi). Remaining cells were stained with directly conjugated fluorescent antibodies for CD4, CD8, CD25, and GITR (if indicated) and sorted by flow cytometry with a FACSAria (Becton Dickenson). Other protocols, such as magnetic bead selection for CD25 hi thymocytes, did not increase the efficiency of this process.
Typical yield from one thymus was on the order of 5 3 10 4 cells.
Cell Culture
Unless otherwise stated, FACS purified thymocytes (5 3 10 3 ) were cultured with or without 5 U/ml human IL-2 in 96-well round bottom plates. Murine IL-7 (5 ng/ml) was also added to promote cell survival ( Figure S7 ). Foxp3 expression was analyzed at 24 hr by flow cytometry with a FACSCanto (Becton Dickenson). This amount of human IL-2 is approximately equivalent to 1 ng/ml or 58.1 pM recombinant murine IL-2 as assayed by Foxp3 induction in CD25 hi cells and would be expected to saturate approximately 90% of high-affinity IL2Rabg receptors. IL-7 (up to 100 ng/ml) in the absence of IL-2 did not increase Foxp3 induction in CD25 lo and CD25 hi cells ( Figure 4B and data not shown).
Intracellular Phospho-STAT5 Staining
Phospho-STAT5 (pSTAT5) was detected as described (Van De Wiele et al., 2004) . Cells were incubated in serum-free DMEM at 1 3 10 6 cells/ml for 10 min at 37 C, then stimulated with either human IL-2 (1000 U/ml) or murine IL-7 (100 ng/ml) for 20 min. Cells were fixed for 15 min at room temperature by 1.5% paraformaldehyde, then washed and resuspended in 100 ml of PBS. To permeabilize the cells, 1 ml of ice-cold methanol was added to the cells while vortexing. After 20 min at 4 C, cells were washed once with PBS and then blocked with 10% calf serum for 15 min at room temperature. Cells were washed and stained in Reagent B (Fix Perm kit, Invitrogen) with Alexa 647-conjugated anti-pSTAT5 for 1 hr at room temperature. Cells were washed three times with 1% BSA in PBS and analyzed by flow cytometry with a FACSAria.
Supplemental Data
Eight supplemental figures are available at http://www.immunity.com/cgi/ content/full/28/1/100/DC1/.
